Chronic inflammatory respiratory diseases, such as asthma, chronic obstructive pulmonary
disease (COPD), and cystic fibrosis, present ongoing challenges in terms of effective …

Asthma affects older adults to the same extent as children and adolescents. However, one is
led to imagine that asthma prevalence decreases with aging and becomes a rare entity in …

Asthma in older populations is characterized by frequent comorbid conditions, which
increase the risk of side effects and of detrimental interactions between respiratory and non …

Objectives This systematic review aimed to discuss the prevalence and the risk factors of the
musculoskeletal pain in chronic obstructive pulmonary disease (COPD). Data source and …

Despite the 2007 National Asthma Education and Prevention Program Expert Panel 3
guidelines for the treatment of uncontrolled asthma, many patients with poorly controlled …

ICS increases risk of bone demineralization and fracture in patients with COPD. It should be
generally avoided in patients with previous fractures or significant osteoporosis. If they are …

Long‐acting bronchodilators and inhaled corticosteroids (ICS) are the cornerstones in
treatment of chronic obstructive and inflammatory pulmonary diseases. However, non …

Chronic obstructive pulmonary disease (COPD) is a prevalent and disabling disorder in the
United States, especially affecting older individuals, women, and those with a history of …

Comorbidities are common in elderly individuals with chronic respiratory diseases. They can
affect disease manifestations and severity and can even impact management. Comorbidities …

Asthma und COPD sind die häufigsten obstruktiven Atemwegserkrankungen. Die
chronische Inflammation bedingt eine Induktion von proinflammatorischen Zytokinkaskaden …